Long-term complications in cases of isolated esophageal atresia treated with esophageal anastomosis.
Long-term follow-up examination with esophagogastroduodenoscopy was performed on seven patients who had undergone successful delayed anastomosis for isolated esophageal atresia. The follow-up period ranged from 1.2 to 11.3 years (mean, 5.3). All patients had undergone fundoplication because of symptomatic gastroesophageal reflux (GER). Three anastomotic strictures had to be resected. At the time of the last follow-up examination, the subjective results were excellent for five patients and good for two. The last endoscopy showed macroscopic esophagitis in three and normal mucosa in four. The fundoplication was partly disrupted in two patients. In three patients the fundoplication was competent but partly intrathoracic. Histological examination showed moderate esophagitis in one, mild esophagitis in one, and normal mucosa in five patients; however, four patients were on continuous medication for esophagitis. In conclusion, the subjective results of patients with isolated esophageal atresia treated with esophageal anastomosis are good. However, long-term complications caused by GER are common in these patients. Therefore, active search and treatment of reflux is necessary for these patients.
D000714:Anastomosis, Surgical / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D020117:Cisapride; D003251:Constriction, Pathologic / Q000209:etiology / Q000473:pathology / Q000601:surgery; D016145:Endoscopy, Digestive System; D004933:Esophageal Atresia / Q000601:surgery*; D004935:Esophageal Diseases / Q000209:etiology / Q000473:pathology / Q000601:surgery; D004941:Esophagitis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D005500:Follow-Up Studies; D018662:Fundoplication; D005764:Gastroesophageal Reflux / Q000209:etiology / Q000473:pathology / Q000601:surgery; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D010880:Piperidines / Q000627:therapeutic use; D011183:Postoperative Complications; D013392:Sucralfate / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D005765:Gastrointestinal Agents; D010880:Piperidines; D013392:Sucralfate; D020117:Cisapride